Agios Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: AGIO
Share price (8/21/26): $33.09
Market cap (8/21/26): $1.976 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from SCHEDULE 13G/A 1 page Power of Attorney

from 10-K 45 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Purchase and Sale Agreement Dated as of October 27, 2022 by and Among Agios Pharmaceuticals, Inc., as Seller the Entities Set Forth on Schedule 1.1, as Purchasers and the Purchaser’s Representative Named Herein

from DEFA14A 122 pages Purchase and Sale Agreement by and Among Agios Pharmaceuticals, Inc., Servier Pharmaceuticals, LLC, And, Solely for Purposes of Section 11.15, Servier S.A.S. Dated as of December 20, 2020

from 8-K 122 pages Purchase and Sale Agreement by and Among Agios Pharmaceuticals, Inc., Servier Pharmaceuticals, LLC, And, Solely for Purposes of Section 11.15, Servier S.A.S. Dated as of December 20, 2020